Bionik Laboratories Corp. Quarterly Nonoperating Income (Expense) in USD from Q1 2015 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Bionik Laboratories Corp. annual/quarterly Nonoperating Income (Expense) history and growth rate from Q1 2015 to Q4 2022.
  • Bionik Laboratories Corp. Nonoperating Income (Expense) for the quarter ending December 31, 2022 was -$32.8K, a 87.2% increase year-over-year.
  • Bionik Laboratories Corp. annual Nonoperating Income (Expense) for 2022 was -$121K, a 72.2% increase from 2021.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$32.8K +$223K +87.2% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-08
Q3 2022 -$18.2K +$208K +92% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q4 2021 -$255K Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-08
Q3 2021 -$226K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q1 2015 $6.39M Jan 1, 2015 Mar 31, 2015 10-KT 2016-06-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.